---
title: "3-AP in Treating Patients With Advanced Prostate Cancer"
description: "RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.\n\nPURPOSE: Phase II trial to study t"
url: "https://www.clareohealth.com/clinical-trials/NCT00054015"
---

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of 3-AP in treating patients who have advanced prostate cancer that has been previously treated with hormone therapy.

## Key Facts

**ID:** NCT00054015
**Status:** COMPLETED
**Phase:** PHASE2
**Type:** INTERVENTIONAL
**Sponsor:** Vion Pharmaceuticals

## About This Study

This clinical trial is testing a drug called 3-AP (Triapine) for men with advanced prostate cancer that has not responded to hormone therapy. The goal is to see how well this drug works and what side effects it may cause.

## Detailed Description

OBJECTIVES: * Determine the response rate in patients with advanced hormone-refractory prostate cancer treated with 3-AP. * Determine the toxic effects of this drug in these patients. OUTLINE: This is a multicenter study. Patients receive 3-AP IV over 2 hours on days 1-4. Treatment repeats every 2 weeks for up to 1 year in the absence of disease progression or unacceptable toxicity. Patients are followed every 2-3 months for up to 1 year. PROJECTED ACCRUAL: Approximately 13-27 patients will be accrued for this study.

## Conditions

- Prostate Cancer

## Interventions

**DRUG: triapine**


## Eligibility

DISEASE CHARACTERISTICS: * Diagnosis of hormone-refractory metastatic prostate cancer by one of the following methods: * Measurable disease * PSA level of at least 5 ng/mL wi…

## Who Can Participate

**Minimum age:** 18

**Sex:** MALE

**Accepts healthy volunteers:** No

## Study Locations

- UCSF Comprehensive Cancer Center, San Francisco, California, United States
- H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

## Contact Information

## Important Dates

**Study start:** December 1, 2002

**Completion date:** January 1, 2008

**Last updated:** November 6, 2013

## Consider Discussing with Your Care Team

### Worth Discussing If

- You have advanced prostate cancer that has not responded to hormone therapy.
- Your cancer has shown signs of progression, like rising PSA levels or new metastases.
- You are looking for new treatment options after previous therapies.
- You are interested in participating in clinical trials for potential access to new treatments.

### Questions to Ask

- Am I eligible for this trial based on my current health and treatment history?
- How does 3-AP compare to other treatments I might consider?
- What side effects should I expect from 3-AP?
- How often will I need to come in for treatment and follow-up visits?
- What happens if my cancer progresses while on this treatment?
- Are there any costs or insurance considerations I should be aware of?

[View on ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT00054015)
